How TRPV1 Channels Explain Both Cannabis Pain Relief and Hyperemesis Syndrome
The TRPV1 ion channel may be the common mechanism behind both cannabis pain relief and the paradoxical cannabinoid hyperemesis syndrome, explaining why capsaicin and hot showers help CHS.
Quick Facts
What This Study Found
TRPV1 activation in the central descending pain pathway (RVM and PAG) mediates antinociception, while peripheral TRPV1 activation mediates nociception. Chronic cannabis use may cause paradoxical hyperemesis through TRPV1-mediated pathways, which explains why capsaicin (a TRPV1 agonist) and hot showers effectively treat CHS.
Key Numbers
Over 450 constituents in cannabis; TRPV1 expressed in both peripheral and central pain pathways; CHS becoming more common with higher-potency products
How They Did This
Review of literature on TRPV1 ion channel interactions with cannabinoids, covering pain pathways, antiemetic mechanisms, and the cannabinoid hyperemesis paradox.
Why This Research Matters
Understanding that a single receptor (TRPV1) mediates both the therapeutic and paradoxical effects of cannabis provides a unifying framework for developing better treatments.
The Bigger Picture
The TRPV1 channel sits at the intersection of pain, nausea, and temperature sensing. Its role in both cannabis benefits and harms suggests that understanding this receptor is key to optimizing cannabinoid medicine.
What This Study Doesn't Tell Us
Review paper synthesizing existing knowledge rather than presenting new data. The TRPV1 mechanism for CHS is proposed but not definitively proven.
Questions This Raises
- ?Could TRPV1-targeted therapies prevent CHS in chronic cannabis users?
- ?Would TRPV1 modulation enhance cannabis pain relief while preventing adverse effects?
Trust & Context
- Key Stat:
- TRPV1 mediates both pain relief and hyperemesis from cannabis
- Evidence Grade:
- Mechanistic review integrating multiple lines of evidence, but the proposed TRPV1 unifying hypothesis needs further experimental validation.
- Study Age:
- Published in 2022
- Original Title:
- TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.
- Published In:
- International journal of molecular sciences, 23(17) (2022)
- Database ID:
- RTHC-04019
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why do hot showers help cannabinoid hyperemesis syndrome?
This review explains that hot water activates TRPV1 channels, the same receptors targeted by capsaicin cream. TRPV1 activation in the vagal-NTS pathway may counteract the nausea and vomiting caused by chronic cannabinoid overstimulation.
How does cannabis relieve pain through TRPV1?
Cannabinoids activate TRPV1 channels in the central descending pain pathway (brainstem regions RVM and PAG), which suppresses pain signals. This is separate from peripheral TRPV1 activation, which can actually increase pain.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04019APA
Louis-Gray, Kathleen; Tupal, Srinivasan; Premkumar, Louis S. (2022). TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.. International journal of molecular sciences, 23(17). https://doi.org/10.3390/ijms231710016
MLA
Louis-Gray, Kathleen, et al. "TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms231710016
RethinkTHC
RethinkTHC Research Database. "TRPV1: A Common Denominator Mediating Antinociceptive and An..." RTHC-04019. Retrieved from https://rethinkthc.com/research/louis-gray-2022-trpv1-a-common-denominator
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.